Advanced or Unresectable Melanoma Progressing After PD1 Blockade Clinical Trials

Advanced or Unresectable Melanoma Progressing After PD1 Blockade

Explore clinical trials studying Advanced or Unresectable Melanoma Progressing After PD1 Blockade. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Advanced or Unresectable Melanoma Progressing After PD1 Blockade trial results

Completed

A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) Blockade

NCT03003676

Conditions: Advanced or Unresectable Melanoma Progressing After PD1 Blockade
Locations: University of Maryland Comprehensive Cancer Center Baltimore, Maryland, United States

Memorial Sloan Kettering Cancer Center New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

Oslo University Hospital - The Norwegian Radium Hospital Oslo, Norway

View Trial Details